Release Date: 14/11/14 11:32 Summary: Annexure A Independent Experts Report for NOM Price Sensitive: No Download Document 471.31KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%